Annual accounts
Full accounts
31/10/2026Filing deadline
Made up to 31/01/2025Due 31/10/2026
- Next accounts made up to
- 31/01/2026
- Last accounts made up to
- 31/01/2025
ELASMOGEN LIMITED
Active- SC467513Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Liberty Building, Foresterhill, Aberdeen AB25 2ZP
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 26/05/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-04-30
- 21/04/2026View PDF (1 pages)
Termination of appointment of Andrew Justin Radcliffe Porter as a director on 2026-03-31
- 03/02/2026View PDF (7 pages)
Confirmation statement made on 2026-01-15 with updates
- 28/01/2026View PDF (1 pages)
Termination of appointment of Lucy Edwardes-Jones as a director on 2026-01-15
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 36 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 15/01/2027
- Last statement dated
- 31/01/2025
Financial performance
The latest figures ELASMOGEN LIMITED filed. Okredo holds filed accounts data for 2023–2025; the year-by-year record is on the financials page.
Net Assets
£2.81M2025
-37.47%vs 20242024: £4.49M
Total Assets
£152.32K2025
-21.43%vs 20242024: £193.87K
Cash in Bank
£2.31M2025
-42.15%vs 20242024: £3.99M
Employees
172025
-1vs 20242024: 18
Of the 3 measures with an earlier filing to compare against, 3 fell. Net assets moved furthest, down 37.47% on 2024. See the full financial analysis for ELASMOGEN LIMITED.
The full financial record
Four ways through ELASMOGEN LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -35.3% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved4 chartsCharts by indicator4 filed indicators plotted year by year, 2023–2025.Plot the figuresNothing estimatedRatios from the filed figures2 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 3 yearsEvery figure by yearAll 5 measures Okredo tracks across 3 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2023–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 17 | -1 |
| 2024 | 18 | +7 |
| 2023 | 11 | – |
Reported employee count increased from 11 in 2023 to 17 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
14Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Corporate Secretary | 15/01/2014–13/11/2015 | 584 | |
| Corporate Director | 15/01/2014–31/01/2014 | 35 | |
| Director | 15/01/2014–31/01/2014 | 203 | |
| Director | 29/04/2022–Present | 9 | |
| Director | 04/04/2017–02/01/2023 | 19 | |
| Director | 24/09/2015–Present | 1 | |
| Director | 05/04/2017–Present | 68 | |
| Director | 31/01/2014–24/09/2015 | 11 | |
| Director | 16/03/2018–18/06/2020 | 11 | |
| Director | 29/04/2022–14/09/2023 | 3 | |
| Director | 13/11/2015–31/03/2026 | 14 | |
| Director | 05/04/2017–16/03/2018 | 9 | |
| Director | 30/08/2022–Present | 5 | |
| Director | 14/09/2023–15/01/2026 | 1 |
Persons with significant control
3Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 02/01/2018–29/01/2021 | 0 | |
| 15/01/2017–08/09/2017 | 0 | |
| 06/04/2016–02/01/2018 | 1 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 17 Since 27/10/2022
- Last 12 months
- 4 +2 vs the year before
- Most recent filing
- 26/05/2026 4 months ago
What changed in the last year
- Share capitalLatest 26/05/2026
- Officer changes (2)Latest 21/04/2026
- Confirmation statementLatest 03/02/2026
Filing timeline
- 26/05/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-04-30
- 21/04/2026View PDF (1 pages)
Termination of appointment of Andrew Justin Radcliffe Porter as a director on 2026-03-31
- 03/02/2026View PDF (7 pages)
Confirmation statement made on 2026-01-15 with updates
- 28/01/2026View PDF (1 pages)
Termination of appointment of Lucy Edwardes-Jones as a director on 2026-01-15
- 07/05/2025View PDF (12 pages)
Full accounts made up to 2025-01-31
- 16/01/2025View PDF (5 pages)
Confirmation statement made on 2025-01-15 with updates
- 03/07/2024View PDF (12 pages)
Full accounts made up to 2024-01-31
- 22/01/2024View PDF (3 pages)
Confirmation statement made on 2024-01-15 with no updates
- 16/10/2023View PDF (1 pages)
Termination of appointment of Keith John Barclay as a director on 2023-09-14
- 16/10/2023View PDF (2 pages)
Appointment of Lucy Edwardes-Jones as a director on 2023-09-14
- 07/08/2023View PDF (11 pages)
Accounts for a small company made up to 2023-01-31
- 28/04/2023View PDF (2 pages)
Resolutions
Showing 12 of 17 filings
See when the next accounts and confirmation statement are due
Similar companies
45 UK companies are similar to ELASMOGEN LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
SOLIVUS LIMITED
Active5th Floor Sustainable Ventures, County Hall, Westminster Bridge Road, London SE1 7PB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 10076849
- Incorporated
- 22/03/2016
- Employees
- 18
FIBROFIND LTD
ActiveUnit 26-27, The Pantry Bakers Yard, Christon Road, Newcastle Upon Tyne NE3 1XD
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11694429
- Incorporated
- 23/11/2018
- Employees
- 16
52 NORTH HEALTH LTD
ActiveKetton Suite The King Centre, Main Road, Barleythorpe, Oakham LE15 7WD
- Activity
- Research and experimental development on biotechnology
- Company no.
- 11460425
- Incorporated
- 11/07/2018
- Employees
- 18
LEVISTOR LTD
Active2 Old Court Mews, 311a Chase Road, London N14 6JS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 13216670
- Incorporated
- 22/02/2021
- Employees
- 15
ANTIVERSE LTD
ActiveSbarc, Spark 5th Floor, Maindy Rd, Cardiff CF24 4HQ
- Activity
- Research and experimental development on biotechnology
- Company no.
- 10736975
- Incorporated
- 24/04/2017
- Employees
- 15
About ELASMOGEN LIMITED
A short description of the company, written from its Companies House record.
ELASMOGEN LIMITED is a private limited company registered in the United Kingdom, based in Liberty Building, Foresterhill, Aberdeen AB25 2ZP. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 12 years 8 months.
The register currently records it as active. Its 2025 accounts report net assets of £2.81M and 17 employees.
ELASMOGEN LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does ELASMOGEN LIMITED do?
Companies House records ELASMOGEN LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is ELASMOGEN LIMITED still active?
ELASMOGEN LIMITED is recorded as active on the Companies House register, and has been on it since 15/01/2014.
What are ELASMOGEN LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £2.81M, total assets of £152.32K and cash in bank of £2.31M.
When did ELASMOGEN LIMITED last file with Companies House?
The most recent document on the record is dated 26/05/2026: Statement of capital following an allotment of shares on 2026-04-30, 4 months ago.
When are ELASMOGEN LIMITED's next filings due?
On the current registry record, accounts are due by 31/10/2026.
Who runs ELASMOGEN LIMITED?
Companies House lists 14 officers (4 currently in post) and 3 people with significant control (0 current).